Is Goserelin legal in the US?
Yes, FDA approved for prostate cancer, endometriosis and other uses.
Goserelin is FDA-approved as Zoladex, a subcutaneous implant first approved in 1989. Its labelled indications are palliative treatment of advanced prostate cancer, use with flutamide and radiotherapy in locally advanced prostate cancer, endometriosis, thinning of the uterine lining before ablation surgery, and palliative treatment of advanced breast cancer in pre- and perimenopausal women. 2
Yes, as Zoladex, since 1989. The current label covers advanced and locally advanced prostate cancer, endometriosis and endometrial thinning before ablation. It also covers advanced breast cancer in pre- and perimenopausal women. 2
More on Goserelin
Citations
- Kaufmann 2003, European Journal of Cancer: survival analyses from the ZEBRA study, goserelin versus CMF in premenopausal node-positive breast cancer doi.org
- FDA 2026: Zoladex (goserelin implant) prescribing information accessdata.fda.gov
Reference information only, not medical advice. Drawn from the Goserelin article, fact-checked against the cited sources. No dosing anywhere on this site.